Allschwil, Switzerland, May 29, 2019
Polyphor and the University of Zurich (UZH) announce today that Innosuisse, the Swiss Innovation Agency, has awarded a significant grant for the innovation project “Development of a new class of antibiotics inhibiting the lipopolysaccharide (LPS) transport pathway”. Innosuisse, formerly known as CTI (Commission of Technology and Innovation) helps to fund innovation projects carried out by companies in cooperation with research institutions. The Innosuisse award will finance the salaries and material costs of Polyphor’s project partner UZH, whereas Polyphor will provide an additional contribution, of which a substantial part will be in kind. The research is independent from the project recently funded by Carb-X and the Novo Repair Fund.
Full PR available here